Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

342.78
BATS BZX Real-Time Price
As of 9:53am ET
 +0.37 / +0.11%
Today’s Change
244.28
Today|||52-Week Range
348.84
+7.60%
Year-to-Date
Sanofi to Acquire Haemophilia Focused Bioverativ, Stock Dips
9:41am / Zacks.com - Paid Partner Content
Five Cheap Stocks With Growing Book Value
Jan 18 / GuruFocus News - Paid Partner Content
Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?
9:19am / Zacks.com - Paid Partner Content
Charter Trust Co Buys iShares Core MSCI Emerging Markets, The Home Depot Inc, iShares...
Jan 17 / GuruFocus News - Paid Partner Content
Sanofi Strikes $11.6 Billion Deal for Bioverativ
5:29am / TheStreet.com - Paid Partner Content
Legacy Private Trust Co. Buys iShares 20+ Year Treasury Bond ETF, SPDR Bloomberg Barc...
Jan 16 / GuruFocus News - Paid Partner Content
Catawba Capital Management Buys Automatic Data Processing Inc, Parker Hannifin Corp,...
Jan 19 / GuruFocus News - Paid Partner Content
3 Pharma and Biotech Stocks to Watch Out for in 2018
Jan 15 / Zacks.com - Paid Partner Content
M&A Rumors Rise Again
Jan 19 / TheStreet.com - Paid Partner Content
Roche MS Drug Ocrevus Gets Marketing Authorization in Europe
Jan 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close342.41
Today’s open344.00
Day’s range342.78 - 345.64
Volume5,416
Average volume (3 months)1,226,882
Market cap$72.4B
Data as of 9:53am ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+8.81%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+9.37%
P/E ratio21.1
Price/Sales6.09
Price/Book6.09

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.62+0.25%
GILDGilead Sciences+0.68+0.84%
----
BIVVBioverativ Inc+40.05+62.47%
Data as of 9:54am ET, 01/22/2018

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$5.45
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts